title: The hormesis database: the occurrence of hormetic dose responses in the toxicological literature.
abstract: In 2005 we published an assessment of dose responses that satisfied a priori evaluative criteria for inclusion within the relational retrieval hormesis database (Calabrese and Blain, 2005). The database included information on study characteristics (e.g., biological model, gender, age and other relevant aspects, number of doses, dose distribution/range, quantitative features of the dose response, temporal features/repeat measures, and physical/chemical properties of the agents). The 2005 article covered information for about 5000 dose responses; the present article has been expanded to cover approximately 9000 dose responses. This assessment extends and strengthens the conclusion of the 2005 paper that the hormesis concept is broadly generalizable, being independent of biological model, endpoint measured and chemical class/physical agent. It also confirmed the definable quantitative features of hormetic dose responses in which the strong majority of dose responses display maximum stimulation less than twice that of the control group and a stimulatory width that is within approximately 10-20-fold of the estimated toxicological or pharmacological threshold. The remarkable consistency of the quantitative features of the hormetic dose response suggests that hormesis may provide an estimate of biological plasticity that is broadly generalized across plant, microbial and animal (invertebrate and vertebrate) models.
authors.affiliation: Department of Public Health, Environmental Health Sciences Division, School of Public Health an Health Sciences, Morrill I, N344, University of Massachusetts, Amherst, MA 01003, USA. edwardc@schoolph.umass.edu
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Calabrese
authors.forename: Robyn B
authors.initials: RB
authors.lastname: Blain
mesh_terms: D000818:Animals; D035061:Control Groups; D016208:Databases, Factual; D004305:Dose-Response Relationship, Drug; D064420:Drug-Related Side Effects and Adverse Reactions; D023381:Endpoint Determination / Q000379:methods*; D005260:Female; D015386:Hazardous Substances / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*; D059165:Hormesis; D006801:Humans; D008297:Male; D051379:Mice; D023421:Models, Animal; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010944:Plants; D051381:Rats; D012107:Research Design; D018570:Risk Assessment / Q000379:methods; D013997:Time Factors
chemical_list: D015386:Hazardous Substances; D004364:Pharmaceutical Preparations